Abstract
We thank Aw et al for their letter and commend them on their study of clinical outcomes in 247 patients at Khoo Teck Puat Hospital in Singapore who underwent platelet reactivity testing to guide antiplatelet therapy after percutaneous coronary intervention and also had CYP2C19 genotype testing performed. We highlight 3 key findings from their study, which complement our recent single-center study at the University of North Carolina at Chapel Hill and the multi-center study conducted by the Implementing Genomics in Practice Network.1,2 First, …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
